1
|
Kuźnicki J and Filipek A: Purification and
properties of a novel Ca2+-binding protein (10.5 KDa) from
Ehrlich-ascites-tumour cells. Biochem J. 247:663–667. 1987.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Kuźnicki J, Kordowska J, Puzianowska M and
Wozniweicz BM: Calcyclin as a marker of human epithelial cells and
fibroblasts. Exp Cell Res. 200:425–430. 1992. View Article : Google Scholar : PubMed/NCBI
|
3
|
Leśniak W, Słomnicki ŁP and Filipek A:
S100A6-new facts and features. Biochem Biophys Res Commun.
390:1087–1092. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Duan L, Wu R, Zou Z, Wang H, Ye L, Li H,
Yuan S, Li X, Zha H, Sun H, et al: S100A6 stimulates proliferation
and migration of colorectal carcinoma cells through activation of
the MAPK pathways. Int J Oncol. 44:781–790. 2014.PubMed/NCBI
|
5
|
Li Y, Wagner ER, Yan Z, Wang Z, Luther G,
Jiang W, Ye J, Wei Q, Wang J, Zhao L, et al: The calcium-binding
protein S100A6 accelerates human osteosarcoma growth by promoting
cell proliferation and inhibiting osteogenic differentiation. Cell
Physiol Biochem. 37:2375–2392. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Luu HH, Zhou L, Haydon RC, Deyrup AT,
Montag AG, Huo D, Heck R, Heizmann CW, Peabody TD, Simon MA and He
TC: Increased expression of S100A6 is associated with decreased
metastasis and inhibition of cell migration and anchorage
independent growth in human osteosarcoma. Cancer Lett. 229:135–148.
2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zihao G, Jie Z, Yan L, Jing Z, Jing C, Xue
L, Jing Z, Heng LW, Ru G and Jianyu H: Analyzing S100A6 expression
in endoscopic ultrasonography-guided fine-needle aspiration
specimens: A promising diagnostic method of pancreatic cancer. J
Clin Gastroenterol. 47:69–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nishi M, Matsumoto K, Kobayashi M,
Yanagita K, Matsumoto T, Nagashio R, Ishii D, Fujita T, Sato Y and
Iwamura M: Serum expression of S100A6 is a potential detection
marker in patients with urothelial carcinoma in the urinary
bladder. Biomed Res. 35:351–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang J, Zhang K, Jiang X and Zhang J:
S100A6 as a potential serum prognostic biomarker and therapeutic
target in gastric cancer. Dig Dis Sci. 59:2136–2144. 2014.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Giudice LC and Kao LC: Endometriosis.
Lancet. 364:1789–1799. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Clever H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wend P, Holland JD, Ziebold U and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Semin
Cell Dev Biol. 21:855–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Matsuzaki S, Darcha C, Maleysson E, Canis
M and Mage G: Impaired down-regulation of E-cadherin and
beta-catenin protein expression in endometrial epithelial cells in
the mid-secretory endometrium of infertile patients with
endometriosis. J Clin Endocrinol Metab. 95:3437–3445. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Xiaoling Z, Lin Q, Xiaohong Y, Huihong Z
and Huai L: Expression of S100A6 in eutopic and ectopic endometrium
of ovarian endometriosis patients. Chinese Journal of Practical
Gynecology and Obstetrics. 26:778–780. 2010.
|
15
|
Liu Z, Zhang X, Chen M, Cao Q and Huang D:
Effect of S100A6 over-expression on β-catenin in endometriosis. J
Obstet Gynaecol Res. 41:1457–1462. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ohuchida K, Mizumoto K, Ishikawa N and
Tanaka M: The role of S100A6 in pancreatic cancer development and
its clinical implication as a diagnostic marker and therapeutic
target. Clin Cancer Res. 11:7785–7793. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Fuli Z, Ying Z, Yaning Z, Miao D and Jian
W: Influence of S100A6 siRNA on biological features of human
ovarian cancer cell. Chinese Journal of Woman and Child Health
Research. 25:48–51. 2014.
|
18
|
Yammani RR: S100 proteins in cartilage:
Role in arthritis. Biochim Biophys Acta. 1822:600–606. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Van Dieck J, Brandt T, Teufel DP,
Veprintsev DB, Joerger AC and Fersht AR: Molecular basis of S100
proteins interacting with the p53 homologs p63 and p73. Oncogene.
29:2024–2035. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Shimamoto S, Kubota Y, Tokumitsu H and
Kobayashi R: S100 proteins regulate the interaction of Hsp90 with
Cyclophilin 40 and FKBP52 through their tetratricopeptide repeats.
FEBS Lett. 584:1119–1125. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Schäfer BW, Wicki R, Engelkamp D, Mattei
MG and Heizmann CW: Isolation of a YAC clone covering a cluster of
nine S100 genes on human chromosome lq21: Rationale for a new
nomenclature of the S100 protein family. Cenomics. 25:638–643.
1995.
|
22
|
Schäfer BW and Heizmann CW: The S100
family of EF-hand calcium-binding proteins: Functions and
pathology. Trends Biochem Sci. 21:134–140. 1996. View Article : Google Scholar : PubMed/NCBI
|
23
|
Saleem M, Kweon MH, Johnson JJ, Adhami VM,
Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw
S, et al: S100A4 accelerates tumorigenesis and invasion of human
prostate cancer through the transcriptional regulation of matrix
metalloproteinase 9. Proc Natl Acad Sci USA. 103:14825–14830. 2006.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Du M, Wang G, Ismail TM, Gross S, Fernig
DG, Barraclough R and Rudland PS: S100P dissociates myosin IIA
filaments and focal adhesion sites to reduce cell adhesion and
enhance cell migration. J BiolChem. 287:15330–15344. 2012.
|
25
|
Zhang J, Zhang DL, Jiao XL and Dong Q:
S100A4 regulates migration and invasion in hepatocellular carcinoma
HepG2 cells via NF-kB-dependent MMP-9 signal. Eur Rev Med Pharmacol
Sci. 17:2372–2382. 2013.PubMed/NCBI
|
26
|
Chen H, Yuan Y, Zhang C, Luo A, Ding F, Ma
J, Yang S, Tian Y, Tong T, Zhan Q and Liu Z: Involvement of S100A14
protein in cell invasion by affecting expression and function of
matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional
regulation. J Biol Chem. 287:17109–17119. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li Z, Tang M, Ling B, Liu S, Zheng Y, Nie
C, Yuan Z, Zhou L, Guo G, Tong A and Wei Y: Increased expression of
S100A6 promotes cell proliferation and migration in human
hepatocellular carcinoma. J Mol Med(Berl). 92:291–303. 2014.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Swiersz LM: Role of endometriosis in
cancer and tumor development. Ann N Y Acad Sci. 955:281–295,
396–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
29
|
Spuijbroek MD, Dunselman GA, Menheere PP
and Evers JL: Early endometriosis invades the extracellular matrix.
Fertil Steril. 58:929–933. 1992. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liang JY, Li CD and Zhang WY: Effects of
activating and inhibiting Wnt/β-catenin signaling pathway on murine
model of eutopic endometrium and endometriosis. Zhonghua Yi Xue Za
Zhi. 92:1352–1356. 2012.(In Chinese). PubMed/NCBI
|
31
|
Kilańczyk E, Graczyk A, Ostrowska H,
Kasacka I, Leśniak W and Filipek A: S100A6 is transcriptionally
regulated by β-catenin and interacts with a novel target, lamin
A/C, in colorectal cancer cell. Cell Calcium. 51:470–477. 2012.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Lee YT, Dimitrova YN, Schneider G,
Ridenour WB, Bhattacharya S, Soss SE, Caprioli RM, Filipek A and
Chazin WJ: Structure of the S100A6 complex with a fragment from the
c-terminal domain of Siah-1 interacting protein: A novel mode for
S100 protein target recognition. Biochemistry. 47:10921–10932.
2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Fuchs SY, Ougolkow AV, Spiegelman VS and
Minamoto T: Oncegenice beta-catenin signaling networks in
colorectal cancer. Cell Cycle. 4:1522–1539. 2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Shaco-Levy R, Sharabi S, Benharroch D,
Piura B and Sion-Vardy N: Matrix metalloproteinases 2 and 9,
E-cadherin, and beta-catenin expression in endometriosis, loe-grade
endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J
Obstet Gynecol Reprod Biol. 139:226–232. 2008. View Article : Google Scholar : PubMed/NCBI
|